Latest Period
Q2 2026
Security Snapshot
TENET HEALTHCARE CORP - COMMON STOCK (THC) Institutional Ownership
CUSIP: 88033G407
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
678
Shares (Excl. Options)
80,463,710
Price
$187.08
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- THC on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 80,463,710
- Total 13F value
- $15,058,086,466
- Portfolio coverage rank
- 0.01%
- Share change
- -1,444,896
- Value change
- -$275,888,078
- Number of holders
- 678
- Shares outstanding
- 86,466,587
- SEC-reported price per share
- $233.20
- Insider filing price
- $233.20
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- THC - TENET HEALTHCARE CORP - COMMON STOCK is tracked under CUSIP 88033G407.
- 678 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 694 to 678 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $15,480,866,396 to $15,058,086,466.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 678 institutions filings for Q2 2026.
Security key
88033G407
Latest holder period
Q2 2026
13F holders
678
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
THC full holder history
TENET HEALTHCARE CORP SEC filings
TENET HEALTHCARE CORP company facts
TENET HEALTHCARE CORP insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 88033G407:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
THC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.8% | $1,024,603,493 | 8,391,511 | BlackRock, Inc. | 31 Mar 2025 | |||
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.2% | $1,640,783,037 | 7,954,926 | T. Rowe Price Associates, Inc. | 30 Jun 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.3% | $864,671,673 | 4,582,013 | Vanguard Capital Management | 31 Mar 2026 | |||
| Invesco Ltd. | 4.4% | $509,469,088 | 4,172,556 | Invesco Ltd. | 31 Mar 2025 | |||
| FMR LLC | 4.6% | $823,914,932 | 3,994,545 | FMR LLC | 30 Jun 2026 |
As of 30 Jun 2026, 678 institutional investors reported holding 80,463,710 shares of TENET HEALTHCARE CORP - COMMON STOCK (THC). This represents 93% of the company’s total 86,466,587 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
67%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10% | 8,743,005 | +0.44% | 0.02% | $1,635,641,325 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.2% | 7,957,449 | +5.8% | 0.15% | $1,488,680,000 |
| Boston Partners | 5.1% | 4,433,360 | +16% | 0.74% | $829,063,147 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9% | 4,238,108 | -1.8% | 0.04% | $792,865,245 |
| FMR LLC | 4.6% | 3,994,545 | -49% | 0.03% | $747,299,553 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 3,894,189 | -0.44% | 0.02% | $728,524,878 |
| STATE STREET CORP | 3.2% | 2,751,290 | +1.3% | 0.02% | $514,711,333 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 2.6% | 2,235,666 | +47% | 8.4% | $418,248,395 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 1,884,982 | -2.4% | 0.02% | $352,719,448 |
| CITADEL ADVISORS LLC | 2% | 1,765,596 | +322% | 0.19% | $330,307,700 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2% | 1,708,453 | +154% | 0.14% | $319,617,387 |
| AMERIPRISE FINANCIAL INC | 1.9% | 1,664,068 | +12% | 0.06% | $311,455,335 |
| DIMENSIONAL FUND ADVISORS LP | 1.7% | 1,450,408 | +21% | 0.05% | $271,349,653 |
| Invesco Ltd. | 1.6% | 1,416,948 | -21% | 0.02% | $265,082,632 |
| VICTORY CAPITAL MANAGEMENT INC | 1.4% | 1,237,915 | +61% | 0.13% | $231,589,138 |
| NORGES BANK | 1.4% | 1,214,240 | 0.02% | $227,160,019 | |
| AQR CAPITAL MANAGEMENT LLC | 1.2% | 1,067,556 | -26% | 0.07% | $198,266,419 |
| ALLIANCEBERNSTEIN L.P. | 1.1% | 910,270 | +30% | 0.06% | $171,777,052 |
| MANNING & NAPIER ADVISORS LLC | 1% | 901,645 | 2.2% | $168,760,895 | |
| BANK OF AMERICA CORP /DE/ | 0.99% | 854,858 | +11% | 0.01% | $159,926,924 |
| MORGAN STANLEY | 0.96% | 831,612 | +4.5% | 0.01% | $155,578,325 |
| T. Rowe Price Investment Management, Inc. | 0.92% | 793,887 | +321% | 0.1% | $148,521,000 |
| NORTHERN TRUST CORP | 0.9% | 781,265 | -0.51% | 0.02% | $146,159,056 |
| Pentwater Capital Management LP | 0.88% | 765,000 | +512% | 1.1% | $143,116,200 |
| Allianz Asset Management GmbH | 0.87% | 753,614 | -1.9% | 0.15% | $142,214,499 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 80,463,710 | $15,058,086,466 | -$275,888,078 | $187.08 | 678 |
| 2026 Q1 | 82,010,795 | $15,480,866,396 | -$472,535,281 | $188.71 | 694 |
| 2025 Q4 | 84,556,105 | $16,805,308,136 | +$194,480,900 | $198.72 | 703 |
| 2025 Q3 | 83,524,934 | $16,956,383,383 | -$548,485,967 | $203.04 | 673 |
| 2025 Q2 | 86,705,205 | $15,256,042,920 | -$242,114,800 | $176.00 | 619 |
| 2025 Q1 | 88,102,608 | $11,848,580,868 | -$297,990,635 | $134.50 | 557 |
| 2024 Q4 | 90,782,644 | $11,460,937,238 | +$74,973,470 | $126.23 | 571 |
| 2024 Q3 | 88,853,987 | $14,755,648,870 | -$388,930,023 | $166.20 | 596 |
| 2024 Q2 | 92,054,252 | $12,246,548,506 | -$231,494,763 | $133.03 | 522 |
| 2024 Q1 | 93,979,649 | $9,878,072,066 | +$21,023,735 | $105.11 | 448 |
| 2023 Q4 | 95,052,239 | $7,183,420,124 | -$61,999,835 | $75.57 | 420 |
| 2023 Q3 | 96,023,570 | $6,326,878,906 | -$70,153,915 | $65.89 | 405 |
| 2023 Q2 | 95,766,096 | $7,793,537,068 | -$238,287,442 | $81.38 | 410 |
| 2023 Q1 | 99,389,967 | $5,903,975,587 | -$260,800,223 | $59.42 | 359 |
| 2022 Q4 | 104,685,581 | $5,107,056,484 | -$189,448,183 | $48.79 | 349 |
| 2022 Q3 | 107,996,779 | $5,568,387,416 | +$91,465,890 | $51.58 | 346 |
| 2022 Q2 | 105,740,110 | $5,559,583,262 | -$63,755,091 | $52.56 | 347 |
| 2022 Q1 | 105,282,868 | $9,052,535,353 | +$282,827,156 | $85.96 | 388 |
| 2021 Q4 | 102,521,862 | $8,374,229,051 | +$119,235,986 | $81.69 | 361 |
| 2021 Q3 | 100,968,332 | $6,709,151,477 | +$55,798,127 | $66.44 | 326 |
| 2021 Q2 | 100,293,045 | $6,718,584,522 | +$246,651,010 | $66.99 | 314 |
| 2021 Q1 | 97,408,920 | $5,065,644,752 | -$60,322,413 | $52.00 | 299 |
| 2020 Q4 | 99,122,344 | $3,958,107,321 | -$64,323,227 | $39.93 | 264 |
| 2020 Q3 | 102,234,584 | $2,504,131,936 | +$7,053,786 | $24.51 | 234 |
| 2020 Q2 | 102,228,001 | $1,850,912,849 | +$1,244,953 | $18.11 | 224 |